Reed Smith has announced the dates and topics for it’s 11th annual health care conference from March 17-21, 2024. The conference will be conducted entirely virtually this year with CLE webinars offered throughout the week on important and timely topics for the health care industry.
The schedule of the sessions is below, all of the webinars are free and have each been presumptively approved for CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas, and West Virginia. Applications for CLE credit will also be filed in Colorado, Delaware, Florida, Georgia, Ohio, and Virginia.
Webinars can also be watched on-demand, but viewers who do so will only be able to obtain CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. They will also have to alert Reed Smith to their viewing of the program to obtain credit.
To register for any or all of the webinars, please click here.
Here is the schedule of webinars for the week: (all times are in EST)
Monday March 17
10:30 am to 11:30 am
Safeguarding Medical Device IP Amid an Evolving “Right to Repair”
Gerard Donovan and Chris Brennan discuss emerging risks and best practices for maximizing the value of medical device IP and aftermarket services.
1:00 pm-2:30 pm
Health Care Transactions: An Overview of Recent Developments and Predictions for What’s to Come
Brian Bewley, Nicole Aiken-Shaban, Katie Dunn and Arielle Lusardi will discuss deal flow activity and developments in 2024 as well as predictions for the future given the administration change and shifting policy positions.
Tuesday March 18
10:00 am to 11:00 am
The 340B Program at a Crossroads
Joe Metro will provide a brief overview of the 340B drug discount program followed by an update on expanding program-related litigation and the interaction with other emerging federal drug price regulation programs.
2:00 pm to 3:00 pm
The Future of Administrative Challenges
Lesley Reynolds and David Bender will discuss administrative challenges regarding payment rates, quality rankings, and other issues that may arise in the future.
Wednesday March 19
10:00 am to 11:00 am
Global Antitrust Hot Topics in Health Care: Preparing Health Care and Life Sciences Companies to Navigate the Complex Antitrust Landscape
Michelle Mantine and Natasha Tardif will discuss hot topics in health care antitrust to help prepare companies in the industry to navigate the complex antitrust landscape in the future.
2:30 pm to 3:30 pm
Legal Perspectives on HHS’s AI Strategic Plan for Health Care, Human Services, and Public Health
Vicki Tankle, Wendell Bartnick, Nan Halstead and Sarah Thompson Schick will discuss the U.S. Department of Health and Human Services’ AI Strategic Plan for Health Care, Human Services, and Public Health, breaking down the HHS strategic roadmaps and their impact on quality, safety, efficiency, accessibility, equity, and outcomes in health care, human services, and public health.
Thursday March 20
12:00 pm to 1:00 pm
What You Need to Know About the Current State of Affairs in Washington
Scot Hasselman and Matt Loughran will provide a lightning round update on Federal legislative and regulatory developments in health care.
2:30 pm to 3:30 pm
Is the FCA Unconstitutional?
Sarah Cummings-Stewart, Elizabeth Brandon and Jason Vendel from Arthrex, Inc. will discuss recent case law suggesting the qui tam provisions of the FCA may be unconstitutional.
Friday March 21
1:00 pm to 2:00 pm
Best Practices for Compliance Programs at a Time of Fast-Paced Change and Uncertainty
Paul Pitts, will be joined by Timothy Burke from Radiology Partners, Christine Wiehl from McKesson and Samantha Meadors from Cardiovascular Associates of America to discuss best practices for maintaining an effective compliance program for health care and life science companies.